Hot key words:
Recruits IM19 drug
About Us

Immunochina Pharmaceuticals

Immunochina is committed to the development of CAR-T technology and CAR-T cell products for the treatment of malignant tumors. We have already established a world-class R&D team and will continue to expand our team. We firmly believe that the core competence of our company is motivated by innovative research and development.

Founders of Immunochina, Dr. He Ting, Dr. Lu Xin'an and Dr. Qi Feifei, graduated from School of Life Sciences, Tsinghua University. They have been devoted to the basic and translational research in cancer and immunology, and have mastered multiple CAR-T core techniques.

We believe that humans will find effective ways to combat cancer in the near future. With the development of CAR-T technology, one of the most critical breakthroughs, patients suffering from hematological malignancies will have the opportunity to start a new lease of life.

You are welcome to call for consultation! 010-62886890 Address:3rd Floor, B1 District, Yiyuan, 80 Xingshikou Road, Haidian District, Beijing
Beijing Immunochina Pharmaceuticals Co., Ltd. Copyright 京ICP备15031757号-1 Technical support: fast help cloud